All our News

All Provepharm employees wish you happy holidays and All the Best for 2024.

Discover our wishes in video!

Company joins exclusive club of pioneering B Corp-certified pharmaceutical companies

Opening will enable pharmaceutical company to better provide UK market with direct distribution and client-facing team. UK third direct-selling country for Provepharm, after France and the United States, expanding commercial presence in medical dye and antidote markets
 

In 2022, Provepharm reached an important milestone in its CSR strategy. In this "2023 CSR Impact", the essential elements of our approach have been grouped together.

Provepharm, an international, private and sustainable pharmaceutical company specialized in revitalizing molecules and Pharm-D, a healthcare and pharmaceutical company based in Malaysia with a strong foothold in Singapore, announce today their partnership to launch Proveblue® 5 mg/ml solution for injection in Malaysia.

We are pleased to present our latest Corporate film.

On Tuesday July 18, 2023, the 140 Provepharm employees, some of whom came from the USA and the UK, celebrated the quarter century of the pharmaceutical laboratory in an emblematic place in Marseille, Casa Delauze.

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our US subsidiary which information is not necessarily applicable to France.

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our UK subsidiary which information is not necessarily applicable to France.